The U.S. Food and Drug Administration has approved the first generic formulas of the high blood pressure drugs Cozaar (losartan potassium) and Hyzaar (losartan potassium and hydrochlorothiazide). These generic versions will have the same labels as the brand name forms, including indications that pregnant women in their second and third trimesters should not use the medications.
The Food and Drug Administration (FDA) has given tentative approval to a generic form of the blood-pressure drug Hyzaar. The generic form of the... Read more »
Drugmakers Atlana and Wyeth have sued Schwarz Pharma to stop the rival company from making a generic form of Protonix (pantoprazole). Schwarz Pharma... Read more »
Drugmaker Teva has received tentative approval for a generic form of Protonix delayed-release tablets (pantoprazole sodium). Final approval is... Read more »
The U.S. Food and Drug Administration (FDA) has approved a generic version of the heartburn treatment Protonix. Drugmaker Teva says it will not... Read more »
Drugmaker Wyeth has launched a generic version of their acid-reflux medication Protonix. The launch comes in response to the generic version of... Read more »